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e searched by a cDNA subtraction screen for
differentially expressed transcripts in MCF-7
mammary carcinoma cells grown on tenascin-C
versus ﬁbronectin. On tenascin-C, cells had irregular
shapes with many processes, whereas on ﬁbronectin they
were ﬂat with a cobble stone–like appearance. We found
elevated levels of 14-3-3 tau transcripts and protein in cells
grown on tenascin-C. To investigate the consequences of
 
an increased level of this phospho-serine/threonine–bind-
ing adaptor protein, we transfected MCF-7 cells with a con-
struct encoding full-length 14-3-3 tau protein and selected
clones with the highest expression levels. The morphology
W
 
of these cells on tenascin-C was ﬂat, resembling that of
cells on ﬁbronectin. This was reﬂected by a similar pattern
of F-actin staining on either substratum. Furthermore, the
growth rate on tenascin-C was increased compared with
the parental cells. After transient transfection of HT1080
ﬁbrosarcoma and T98G glioblastoma cells with 14-3-3 tau,
only the 14-3-3 tau–expressing cells were able to adhere
and survive on tenascin-C, whereas all cells adhered well
on ﬁbronectin. Therefore, we postulate that tenascin-C
promotes the growth of tumor cells by causing an increase
in the expression of 14-3-3 tau, which in turn has a positive
effect on tumor cell adhesion and growth.
 
Introduction
 
Tenascin-C is an ECM protein well known for its high
expression in almost all solid tumors and for its antiadhesive
properties for cells in culture (for reviews see Chiquet-
Ehrismann, 1993; Crossin, 1996; Vollmer, 1997; Jones and
Jones, 2000; Orend and Chiquet-Ehrismann, 2000). The
level of tenascin-C expression and the nature of the isoform
expressed seems in a variety of tumors to correlate with a
higher incidence of metastases and poor prognosis (Goepel
et al., 2000; Emoto et al., 2001; Salmenkivi et al., 2001;
Adams et al., 2002; Herold-Mende et al., 2002).
 
Therefore, it is of great interest to find out how tumor cells
react to the presence of tenascin-C. In most of the published
studies to date, effects of tenascin-C on cell adhesion, spreading,
migration, and growth have been reported (for review see
Orend and Chiquet-Ehrismann, 2000). However, the
molecular mechanisms mediating these responses to tenascin-C
remain largely unknown. From previous studies we know
that a tenascin-C substratum supports the growth of rat
primary mammary carcinoma cells more than fibronectin
(Chiquet-Ehrismann et al., 1986). Furthermore, we have
shown that MCF-7 human mammary carcinoma cells induce
tenascin-C expression in cocultured fibroblasts surrounding
the tumor cell nests (Chiquet-Ehrismann et al., 1989).
We therefore decided to screen for transcripts that are
differentially expressed in MCF-7 cells grown on a tenascin-C
versus a fibronectin substratum. We now report on our
discovery that a tenascin-C substratum induces the expression
of the phospho-serine/threonine–binding adaptor protein
14-3-3 tau in MCF-7 mammary carcinoma cells and describe
its influence on cell adhesion and cell growth.
 
Results and discussion
 
MCF-7 cells were grown in medium containing 10% FCS
for 24 h on plates coated with fibronectin or tenascin-C,
respectively. The cells show completely different morphologies
on these two substrates. They grow in epithelial patches on
fibronectin but lose their cell–cell contacts and adopt irregular
shapes with long processes on a tenascin-C substratum (Fig.
1). This is reminiscent of the results obtained with MCF-7
cells grown on collagen gels in the presence and absence of
tenascin-C where the cells in the presence of tenascin-C
were found to loose their cell–cell contacts and detached
from the substratum (Chiquet-Ehrismann et al., 1989). To
identify molecular differences between the cells grown on
fibronectin versus tenascin-C, we isolated mRNA from these
cells and performed a screen for differentially expressed tran-
scripts. This screen resulted in the identification of a cDNA
clone encoding the adaptor protein 14-3-3 tau. 14-3-3
proteins are a family of phospho-serine/threonine–binding
proteins with 
 
 
 
70 known ligands as diverse as kinases,
phosphatases, receptors, structural proteins, and transcription
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factors (for reviews see Fu et al., 2000; van Hemert et al.,
2001; Tzivion and Avruch, 2002). We confirmed the higher
level of 14-3-3 tau transcripts in two mRNA batches isolated
from independently cultured MCF-7 cells on tenascin-C
 
versus fibronectin substrates by semiquantitative PCR. As
shown in Fig. 2 A, transcript levels of GAPDH were equal,
whereas 14-3-3 tau was highly increased in the samples from
the cells cultured on tenascin-C compared with fibronectin.
We next tested whether the level of the 14-3-3 tau protein
was also affected. We loaded equal amounts of cellular pro-
tein on an SDS-PAGE followed by detection of 14-3-3 tau
by a specific antiserum on an immunoblot. As shown in Fig.
2 B, the level of the 14-3-3 protein was also much higher in
cell extracts of cells grown on a tenascin-C substratum than
on fibronectin.
From the literature we know that 14-3-3 proteins are im-
plicated in the regulation of cell growth and oncogenic trans-
formation (Takihara et al., 2000) and that they exhibit anti-
apoptotic activity (Xing et al., 2000; Masters and Fu, 2001).
Therefore, we decided to test for an effect of elevated 14-3-3
tau levels in MCF-7 cells on their adhesion and growth be-
havior when cultured on tenascin-C versus fibronectin sub-
strates. We transfected MCF-7 cells with a construct encod-
ing 14-3-3 tau containing an NH
 
2
 
-terminal Flag tag. Cell
clones were isolated and tested on immunoblots for expres-
sion of the transfected 14-3-3 tau in comparison to the en-
dogenous 14-3-3 tau protein as shown in Fig. 3 A. Clones 2
and 5 exhibiting the highest amount of the transfected 14-
3-3 relative to the endogenous protein were selected for further
experiments. When they were grown on tenascin-C–coated
plates they exhibited a cobble stone–like morphology as on
Figure 1. Morphological changes of MCF-7 cells grown on a 
tenascin-C substratum. MCF-7 cells were cultured for 24 h in complete 
medium on fibronectin-coated (A) and on tenascin-C–coated (B) 
dishes and photographed. On fibronectin, they adopt a cobble-stone–
like epithelial morphology, whereas on tenascin-C they lose the 
cell–cell contacts and adopt irregular shapes. Bar, 200  m.
Figure 2. Induction of 14-3-3 tau in cells grown on tenascin-C. 
(A) Photographs of ethidium bromide-stained agarose gels shows 
RT-PCR reactions of mRNA isolated from MCF-7 cells grown for 
24 h on a fibronectin (FN) or on a tenascin-C (TN) substratum. They 
reveal an increase in 14-3-3 transcripts in cells from the tenascin-C 
substratum, whereas GAPDH expression is equal in both situations. 
The same result was obtained in two independently performed 
experiments (exp. 1 and exp. 2). (B) Amidoblack staining of a 12% 
SDS gel blotted to a PVDF membrane showing equal protein content 
of cell extracts loaded from cells grown on fibronectin (FN) or 
tenascin-C (TN; left). The immunoblot of the same membrane 
obtained with anti–14-3-3 tau reveals a stronger signal in the extract 
from cells grown on tenascin-C than on fibronectin (right).
Figure 3. Isolation of MCF-7 clones overexpressing 14-3-3 tau. 
Cell extracts (not normalized to protein content) of the parental 
MCF-7 cells (M) and of clones 1–5 isolated after transfection with 
Flag-tagged 14-3-3 tau were separated by 12% SDS-PAGE. Immuno-
blots thereof were performed using anti-Flag to identify the product 
from the transfected construct and anti–14-3-3 tau to detect the 
endogenously expressed protein. The two bands could easily be 
distinguished, since the Flag-tagged protein migrated slightly slower 
than the endogenous protein. Clones 2 and 5 (circled numbers), 
exhibiting the strongest band with anti-Flag relative to the presence 
of the endogenous protein were selected for further studies. (B) 
Parental MCF-7 cells and clones 2 and 5 were cultured for 24 h in 
complete medium on a fibronectin versus a tenascin-C substratum 
and photographed. The parental cells showed an altered morphology 
induced by the tenascin-C substratum, whereas no difference was 
visible in the 14-3-3–overexpressing clones 2 and 5. Bar, 20  m.T
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fibronectin, whereas the parental cells showed an irregular
morphology on tenascin-C (Fig. 3 B). This was particularly
well visible in phalloidin-stained cells (Fig. 4 A).
Two more cell lines were analyzed for a similar effect of 14-
3-3 tau on cell adhesion on tenascin-C. HT1080 fibrosar-
coma cells and T98G glioblastoma cells were transiently
transfected with 14-3-3 tau after plating them on either a fi-
bronectin or a tenascin-C substratum. 1 d later, transfected
cells were visualized by staining the Flag tag of the transfected
14-3-3 tau, and all cells were stained by phalloidin (Fig. 4 B).
On fibronectin, a small proportion of the large number of ad-
hering cells expressed 14-3-3 tau, whereas on tenascin-C only
a few cells were present but all expressing 14-3-3 tau. This
implies that in these cells overexpression of 14-3-3 tau also
led to an increased cell adhesion on tenascin-C.
Possibly, this effect is related to the reported interaction of
14-3-3 tau with rap1/B-Raf (Berruti, 2000), since rap1 sig-
naling has been implicated in the regulation of integrin-me-
diated cell adhesion (Bos et al., 2001). Another possibility
could be an interaction of 14-3-3 with integrins themselves
as has been reported for 14-3-3 beta and integrin 
 
 
 
1 (Han et
al., 2001) or for 14-3-3 zeta with the integrin-associated
docking protein p130 (Cas). Finally, an interaction of 14-3-
3 zeta with the actin depolymerizing factor cofilin and its
regulatory kinase LIM kinase 2 has been observed (Birken-
feld et al., 2003), and 14-3-3 zeta seems to stabilize phos-
phocofilin levels (Gohla and Bokoch, 2002), pointing to a
further pathway for 14-3-3 proteins by affecting cell mor-
phology through direct action on the actin cytoskeleton.
We next tested the effect of the overexpression of 14-3-3
tau on cell growth. We plated equal numbers of cells on fi-
bronectin versus tenascin-C substrates in complete medium
and cultured the parental versus the 14-3-3–transfected
clones 2 and 5 for 3 d. After 3 d in culture, the MCF-7 cells
reached higher densities on fibronectin than on tenascin-C,
whereas no distinction could be made for clone 2 or 5, re-
spectively (unpublished data). The lower cell number of the
parental MCF-7 cells on a tenascin-C substratum coincided
with a reduced level of DNA replication on a tenascin-C
substrate in comparison to fibronectin as measured by 
 
3
 
H-
thymidine incorporation (Fig. 5). The 
 
3
 
H-thymidine incor-
poration by the 14-3-3 tau–overexpressing clones 2 and 5
was recovered on tenascin-C and reached values almost as
high as on fibronectin (Fig. 5). A possible mechanism is that
cell cycle progression is stimulated by an interaction of 14-
3-3 with phosphorylated p27
 
Kip1
 
 and by retaining this cell
cycle inhibitor in the cytoplasm (Fujita et al., 2002). Alter-
natively, stimulation of cell growth by 14-3-3 could be indi-
rect by its known inhibitory action on apoptosis (Xing et al.,
2000; Masters and Fu, 2001). To test whether cells on tena-
scin-C were protected from apoptosis by overexpression of
14-3-3 tau, we plated the parental MCF-7 cells and clones 2
and 5 on tenascin-C– and fibronectin-coated wells, respec-
tively, and analyzed the number of apoptotic cells under
Figure 4. Effect of 14-3-3 tau on cell 
morphology and adhesion on fibronectin 
versus tenascin-C substrata. (A) TRITC-
phalloidin staining of MCF-7 parental 
cells and clones 2 and 5 overexpressing 
14-3-3 tau grown in fibronectin-coated 
(FN) or tenascin-C–coated (TN) wells. 
MCF-7 cells are well spread on fibronectin 
but elongated with many actin-rich 
processes on tenascin-C as opposed to 
clones 2 and 5, which how similar 
morphologies on either substratum with 
actin accumulations at the cell peripheries 
of the well spread cells. Bar, 50  m. 
(B) Anti-Flag staining reveals cells over-
expressing transfected 14-3-3–Flag 
(14-3-3), and RITC-phalloidin staining 
shows F-actin in all cells present in 
the same field of cultures of HT1080 
cells and T98G cells grown on either 
fibronectin (FN) or tenascin-C (TN). 
Only the transfected cells were able to 
adhere and survive on the tenascin-C 
substratum, whereas on fibronectin most 
cells remained present. Bar, 50  m.T
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both conditions. However, not even the parental MCF-7
cells showed increased apoptosis on tenascin-C compared
with the cells plated on fibronectin. Reduction of the serum
level in the medium to 1% lead to a concomitant increase in
apoptotic cells on both substrates. Therefore, the hypothesis
that 14-3-3 tau could protect MCF-7 cells from apoptosis
cannot be the reason for the observed increase in growth.
Clearly 14-3-3 proteins are important adaptor proteins
with many target proteins such as Raf-1 (Fantl et al., 1994;
Fu et al., 1994; Li et al., 1995), PKC (Van Der Hoeven et
al., 2000), phosphatidylinositol 3-kinase (Bonnefoy-Berard
et al., 1995), Bad (Zha et al., 1996), and Cdc25 (Kumagai
and Dunphy, 1999) and thus seem to have a central and in-
tegrating role in orchestrating signaling pathways regulating
cell growth and death. Furthermore, their positive effect on
cell adhesion presents an additional input in their capability
of influencing cell behavior. For cells that have not com-
pletely lost their anchorage dependence, this again has a pos-
itive effect on cell growth. Therefore, it is interesting that
tenascin-C, an extracellular matrix protein highly overex-
pressed in cancer tissues, causes an increase in the expression
of 14-3-3 tau in cancer cells. Tenascin-C may, therefore, al-
ter the physiological status of the tumor cells by induction of
14-3-3 tau, thereby promoting their growth.
 
Materials and methods
 
Cell cultures
 
MCF-7 mammary carcinoma cells (HTB-22; American Type Culture Col-
lection), HT1080 fibrosarcoma cells (CCL-121; American Type Culture
Collection), and T98G glioblastoma cells (CRL-1690; American Type Cul-
ture Collection) were cultured in Dulbecco’s medium (Life Technolo-
gies) containing 10% FCS (Amimed) at 37
 
 
 
C and 5% CO
 
2
 
. Substrates of
tenascin-C or fibronectin were prepared by coating these proteins at 25
 
 
 
g/ml in PBS including 0.01% Tween for 1 h at RT. Tenascin-C and fi-
bronectin were purified as described previously (Fischer et al., 1997).
Cell growth was analyzed by measuring the incorporation of 
 
3
 
H-thymi-
dine. Equal numbers of cells were plated on tenascin-C versus fibronectin
in complete medium. After 22 h, the medium was removed, the cell layers
were washed with medium without FCS, and medium containing 0.1%
FCS was added. 22 h later, the cells were labeled with 
 
3
 
H-thymidine for
6 h and harvested and analyzed as described previously (Huang et al.,
2001). Apoptosis was analyzed by TUNEL staining using the In Situ Cell
Death Detection kit (Roche Diagnostics AG) according to the procedure of
the manufacturer.
For immunofluorescence and F-actin staining, cells were fixed with 4%
PFA in PBS for 30 min and permeabilized with 0.1% Trition X-100 in PBS
for 5 min. Then, they were either incubated for 1 h with 0.05 
 
 
 
M TRITC-
phalloidin (Sigma-Aldrich) or with anti-Flag (M2; Stratagene) at a 1:500 di-
lution, or with both simultaneously, all in PBS containing 3% goat serum
for 1 h. Secondary goat anti–mouse Alexa488-conjugated antibodies (Mo-
lecular Probes) diluted 1:1,000 in PBS/3% goat serum were applied for de-
tection of the primary antibodies. Cells were washed in PBS after each in-
cubation. Finally, the specimens were mounted in Mowiol (Calbiochem)
and examined and photographed using a Axiophot microscope (Carl Zeiss
MicroImaging, Inc.) connected to a 3CCD camera (Sony).
 
Subtractive cDNA cloning
 
An Oligotex Direct mRNA kit (QIAGEN) was used to isolate mRNA from
two 10-cm plates of MCF-7 cells grown on either fibronectin or tenascin-C
substrata for 24 h in complete medium. These mRNA samples were used
for RT-PCR reactions and subtractive hybridization using the Advantage
cDNA PCR kit (CLONETECH Laboratories, Inc.) and the PCR-Select cDNA
Subtraction kit (CLONETECH Laboratories, Inc.) according to the manuals
supplied. The PCR products were cloned into pKS and analyzed by se-
quencing. Primers were derived from the insert sequences to verify a differ-
ential expression of the respective transcripts in the two cDNA batches by
semiquantitative PCR reactions using Taq polymerase (Roche Diagnos-
tics AG). To amplify the 14-3-3 tau, we used the following primer pair:
5
 
 
 
-AGTTGCGTGTGGTGATGATCG-3
 
  
 
and 5
 
 
 
-GTATGAGTCTTCATT-
CAGTG-3
 
 
 
. Samples were taken from each reaction after completion of
15, 20, 25, and 30 cycles and analyzed on agarose gels after ethidium bro-
mide staining. This allowed us to verify the linear range of amplification
that we used for comparison.
 
Transfection of 14-3-3–Flag and Western blots
 
A full-length 14-3-3 tau construct containing an NH
 
2
 
-terminal Flag tag
was engineered by RT-PCR from mRNA of MCF-7 cells using the Advan-
tage cDNA PCR kit (CLONETECH Laboratories, Inc.). A first set of 14-3-
3-specific primers was used (5
 
 
 
-GCGGCCGCGGAGACGTGAAC-3
 
 
 
 and
5
 
 
 
-AAGGATGACACCCTGTATGG-3
 
 
 
) followed by a second round of
PCR with (5
 
 
 
-ATGCGGCCGCACCATGGACTACAAGGATGACGATGA-
CAAGATGGAGAAGACTGAGCTG-3
 
 
 
 and 5
 
 
 
-ATCTCGAGTTAGTTT-
TCAGCCCCTTCTGC-3
 
 
 
) to add the Flag tag and the appropriate restric-
tion sites NotI and XhoI at respective ends needed for subsequent cloning
into the expression vector pcDNA3 (Invitrogen). The resulting construct
was verified by sequencing and was called 14-3-3–Flag. It contained the
complete coding sequence of human 14-3-3 tau available from Gen-
Bank/EMBL/DDBJ under accession no. X56468 with an NH
 
2
 
-terminal ex-
tension of a Flag tag. MCF-7 cells were transfected with 14-3-3–Flag us-
ing the transfection reagent fugene (Roche Diagnostics AG), and clones
were selected for by the addition of G418 (Life Technologies). The resis-
tant cell clones were tested for the production of the 14-3-3–Flag protein
on Western blots of cell extracts using anti-Flag (M2; Stratagene), a per-
oxidase-labeled anti–mouse IgG (Cappel/ICN), and the ECL reagent (Am-
ersham Biosciences) for chemiluminescent detection of the reactive
bands. Endogenous synthesis of 14-3-3 tau was detected on the same
blot using anti–14-3-3 theta/tau (Research Diagnostics Inc.). The Flag-
tagged 14-3-3 migrates slightly slower than the endogenous protein due
to the presence of the tag.
HT1080 and T98G cells were each plated on fibronectin and tenascin-
C–coated plates. 1 d later, they were transiently transfected with the 14-3-
3–Flag construct using the transfection reagent fugene. On the next day,
cells were fixed and stained with anti-Flag and phalloidin as described
above for the MCF-7 cells.
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3
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